These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34035870)

  • 21. Providing patient care through community pharmacies in the UK: policy, practice, and research.
    Noyce PR
    Ann Pharmacother; 2007 May; 41(5):861-8. PubMed ID: 17456540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The changing roles of pharmacists in community pharmacies: perception of reality in India.
    Basak SC; van Mil JW; Sathyanarayana D
    Pharm World Sci; 2009 Dec; 31(6):612-8. PubMed ID: 19554470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Cross-Sectional Study on Pharmacy Students' Career Choices in the Light of Saudi Vision 2030: Will Community Pharmacy Continue to Be the Most Promising, but Least Preferred, Sector?
    Almaghaslah D; Alsayari A; Almanasef M; Asiri A
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33926047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community pharmacy practice in China: past, present and future.
    Fang Y; Yang S; Zhou S; Jiang M; Liu J
    Int J Clin Pharm; 2013 Aug; 35(4):520-8. PubMed ID: 23661172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Policy and vision for community pharmacies in Finland: A roadmap towards enhanced integration and reduced costs.
    Airaksinen M; Toivo T; Jokinen L; Savela E; Parkkamäki S; Sandler C; Kalliomäki H; Dimitrow M
    Pharm Pract (Granada); 2021; 19(1):2288. PubMed ID: 33628348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing community pharmacy services in health professional shortage areas across Wisconsin.
    Look KA; Black P; Arzt J; Crahan J; Helgeson CB; Lucey MS; Lee M; Rox KR; Portillo E
    J Am Pharm Assoc (2003); 2024; 64(2):506-511.e3. PubMed ID: 37940092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 600 Years of Town Hall Pharmacy (raeapteek) in Tallinn, Estonia.
    Raal A; Koppel J
    Pharmazie; 2023 Apr; 78(1):20-25. PubMed ID: 37138410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary health care policy and vision for community pharmacy and pharmacists in Colombia.
    Amariles P; Ceballos M; González-Giraldo C
    Pharm Pract (Granada); 2020; 18(4):2159. PubMed ID: 33294064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A realist evaluation of the development of extended pharmacist roles and services in community pharmacies.
    Morris C; McDonald J; Officer TN; Fa'asalele Tanuvasa A; Smiler K; Parore N; Dunn P; McKinlay E; Kennedy J; McBride-Henry K; Cumming J
    Res Social Adm Pharm; 2024 Mar; 20(3):321-334. PubMed ID: 38065764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community pharmacy integration within the primary care pathway for people with long-term conditions: a focus group study of patients', pharmacists' and GPs' experiences and expectations.
    Hindi AMK; Schafheutle EI; Jacobs S
    BMC Fam Pract; 2019 Feb; 20(1):26. PubMed ID: 30736732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary health care policy and vision for community pharmacy and pharmacists in England.
    Anderson C; Sharma R
    Pharm Pract (Granada); 2020; 18(1):1870. PubMed ID: 32256901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Health Care and Community Pharmacy in Ireland: a lot of visions but little progress.
    Henman MC
    Pharm Pract (Granada); 2020; 18(4):2224. PubMed ID: 33294066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical care in community pharmacies: practice and research in Switzerland.
    Guignard E; Bugnon O
    Ann Pharmacother; 2006 Mar; 40(3):512-7. PubMed ID: 16467249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist provider status: Geoprocessing analysis of pharmacy locations, medically underserved areas, populations, and health professional shortage areas.
    Murphy EM; West L; Jindal N
    J Am Pharm Assoc (2003); 2021; 61(6):651-660.e1. PubMed ID: 34531121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care policy and community pharmacy: implications for the New Zealand primary health care sector.
    Scahill S; Harrison J; Carswell P; Shaw J
    N Z Med J; 2010 Jun; 123(1317):41-51. PubMed ID: 20657630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.